These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21511492)

  • 21. [Molecular unraveling of disease by means of DNA-microarrays].
    van der Pouw Kraan CT; Dijkstra CD; Verweij CL
    Ned Tijdschr Geneeskd; 2005 Mar; 149(12):626-31. PubMed ID: 15813429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
    Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome.
    Monni O; Hyman E; Mousses S; Barlund M; Kallioniemi A; Kallioniemi OP
    Semin Cancer Biol; 2001 Oct; 11(5):395-401. PubMed ID: 11562182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression array technology in the diagnosis and treatment of breast cancer.
    Jeffrey SS; Fero MJ; Børresen-Dale AL; Botstein D
    Mol Interv; 2002 Apr; 2(2):101-9. PubMed ID: 14993355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genomic based approach to individualized cancer therapy].
    Isomura M; Miki Y
    Nihon Rinsho; 2010 Jun; 68(6):1117-20. PubMed ID: 20535965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput techniques in breast cancer: a clinical perspective.
    Espinosa E; Redondo A; Vara JA; Zamora P; Casado E; Cejas P; Barón MG
    Eur J Cancer; 2006 Mar; 42(5):598-607. PubMed ID: 16431104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Towards an individualization of systemic treatment of breast tumors].
    Bernard-Marty C; Cardoso F; Sotiriou C; Piccart MJ
    Bull Cancer; 2006 Aug; 93(8):791-7. PubMed ID: 16935784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New molecular classifications of breast cancer.
    Cianfrocca M; Gradishar W
    CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of breast cancer by array comparative genomic hybridization.
    Climent J; Garcia JL; Mao JH; Arsuaga J; Perez-Losada J
    Biochem Cell Biol; 2007 Aug; 85(4):497-508. PubMed ID: 17713584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges.
    Simpson PT; Vargas AC; Al-Ejeh F; Khanna KK; Chenevix-Trench G; Lakhani SR
    Hum Pathol; 2011 Feb; 42(2):153-65. PubMed ID: 21106225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Array-based comparative genomic hybridization in clinical diagnosis.
    Bejjani BA; Theisen AP; Ballif BC; Shaffer LG
    Expert Rev Mol Diagn; 2005 May; 5(3):421-9. PubMed ID: 15934818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
    Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
    Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us?
    Sims AH
    J Clin Pathol; 2009 Oct; 62(10):879-85. PubMed ID: 19174421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological markers in breast cancer prognosis and treatment.
    Kesisis G; Kontovinis LF; Gennatas K; Kortsaris AH
    J BUON; 2010; 15(3):447-54. PubMed ID: 20941809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX.
    Kaklamani V
    Expert Rev Mol Diagn; 2006 Nov; 6(6):803-9. PubMed ID: 17140367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of genomic instability in the diagnosis and treatment of breast cancer.
    Wiechec E
    Expert Rev Mol Diagn; 2011 May; 11(4):445-53. PubMed ID: 21545260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of applied research for prognosis and therapy of breast cancer.
    Barginear MF; Bradley T; Shapira I; Budman DR
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):223-34. PubMed ID: 18243013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular profiling of breast cancer.
    Paik S
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):59-63. PubMed ID: 16493262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.